280 related articles for article (PubMed ID: 8988053)
1. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T
Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053
[TBL] [Abstract][Full Text] [Related]
2. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
[TBL] [Abstract][Full Text] [Related]
3. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ
Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521
[TBL] [Abstract][Full Text] [Related]
4. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.
Blagosklonny MV; Schulte T; Nguyen P; Trepel J; Neckers LM
Cancer Res; 1996 Apr; 56(8):1851-4. PubMed ID: 8620503
[TBL] [Abstract][Full Text] [Related]
5. Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells.
Blagosklonny MV; Bishop PC; Robey R; Fojo T; Bates SE
Cancer Res; 2000 Jul; 60(13):3425-8. PubMed ID: 10910051
[TBL] [Abstract][Full Text] [Related]
6. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
Ibrado AM; Liu L; Bhalla K
Cancer Res; 1997 Mar; 57(6):1109-15. PubMed ID: 9067280
[TBL] [Abstract][Full Text] [Related]
7. Implication of bax in apoptosis depends on microtubule network mobility.
Longuet M; Serduc R; Riva C
Int J Oncol; 2004 Aug; 25(2):309-17. PubMed ID: 15254727
[TBL] [Abstract][Full Text] [Related]
8. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation.
Attalla H; Westberg JA; Andersson LC; Adlercreutz H; Mäkelä TP
Biochem Biophys Res Commun; 1998 Jun; 247(3):616-9. PubMed ID: 9647742
[TBL] [Abstract][Full Text] [Related]
9. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.
Fan M; Du L; Stone AA; Gilbert KM; Chambers TC
Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt.
Asnaghi L; Calastretti A; Bevilacqua A; D'Agnano I; Gatti G; Canti G; Delia D; Capaccioli S; Nicolin A
Oncogene; 2004 Jul; 23(34):5781-91. PubMed ID: 15208671
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Taxol-induced cell death are concentration dependent.
Torres K; Horwitz SB
Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
[TBL] [Abstract][Full Text] [Related]
12. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
13. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
Stone AA; Chambers TC
Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
15. Genistein inversely affects tubulin-binding agent-induced apoptosis in human breast cancer cells.
Liao CH; Pan SL; Guh JH; Teng CM
Biochem Pharmacol; 2004 Jun; 67(11):2031-8. PubMed ID: 15135300
[TBL] [Abstract][Full Text] [Related]
16. Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase.
Calastretti A; Bevilacqua A; Ceriani C; Viganò S; Zancai P; Capaccioli S; Nicolin A
Oncogene; 2001 Sep; 20(43):6172-80. PubMed ID: 11593425
[TBL] [Abstract][Full Text] [Related]
17. Loss of the bcl-2 phosphorylation loop domain increases resistance of human leukemia cells (U937) to paclitaxel-mediated mitochondrial dysfunction and apoptosis.
Wang S; Wang Z; Boise L; Dent P; Grant S
Biochem Biophys Res Commun; 1999 May; 259(1):67-72. PubMed ID: 10334917
[TBL] [Abstract][Full Text] [Related]
18. Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction.
Du L; Lyle CS; Chambers TC
Oncogene; 2005 Jan; 24(1):107-17. PubMed ID: 15531923
[TBL] [Abstract][Full Text] [Related]
19. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells.
Cheung HW; Ling MT; Tsao SW; Wong YC; Wang X
Carcinogenesis; 2004 Jun; 25(6):881-7. PubMed ID: 14742319
[TBL] [Abstract][Full Text] [Related]
20. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells.
Haldar S; Chintapalli J; Croce CM
Cancer Res; 1996 Mar; 56(6):1253-5. PubMed ID: 8640809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
